Delivery Order SPE2DB20D3103-SPE2DB25FM2D1

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $20,718.28 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,662,809 units of the pharmaceutical product Ganirelix Acetate 250 mcg/0.5 mL. This contract does not have a set-aside designation and has a completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,534.38 Firm Fixed Price Delivery Order covers the supply of GANIRELIX ACET 250 MCG/0.5 ML 0.0.5ML, a medical product, to support federal healthcare programs. The award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558972905 GANIRELIX ACET 250 MCG/0.5 ML 0.5ML. The contract, valued at $3,388.08, is a firm fixed price delivery order with a completion date of November 3, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $14,531.71 firm fixed price contract is for the supply of the pharmaceutical product Ganirelix Acetate 250 mcg/0.5 ml, with a performance period ending on May 8, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a single-award Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp Corporate Office division. The contract is for the delivery of 4,565,076,355 units of the pharmaceutical product Ganirelix Acetate 250 MCG/0.5 ML, with a ceiling value of $9,383.50. The contract has a firm-fixed price pricing type and an ultimate completion date of July 8, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $11,096.11 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of the pharmaceutical product "GANIRELIX ACET 250 MCG/0.5 ML 0.5ML". The award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,746.69 firm fixed-price delivery order is for the supply of Ganirelix Acetate, a medication used in infertility treatments. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of GANIRELIX ACET 250 MCG/0.5 ML 0.5ML pharmaceutical products. The $14,602.49 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distributor, holds two Indefinite Delivery Contracts...
This federal contract award is for the delivery of Ganirelix Acetate 250 mcg/0.5 mL pharmaceutical products to the Defense Logistics Agency (DLA). The contract, worth $7,031.00, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract does not have any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $9,797.84 for the supply of the pharmaceutical drug Ganirelix Acetate 250 mcg/0.5 mL 0.5mL. The contract has an ultimate completion date of July 11, 2024 and was awarded on July 10, 2024. The prime contractor, Amerisourcebergen Drug Corp, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM2D1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,735.56 Firm Fixed Price delivery order is for the drug Ganirelix Acetate 250 MCG/0.5 ML 0.5ML, with a completion date of January 7, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is made against that larger IDC contract. The contract did not have a set-aside designation, indicating open competition.

Generated 4/13/25, 12:45 AM